KARL STORZ ENDOSCOPY (UK) LIMITED

Company Registration Number:
SC151965 (Scotland)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 1 January 2024

End date: 31 December 2024

KARL STORZ ENDOSCOPY (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

KARL STORZ ENDOSCOPY (UK) LIMITED

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal activities of the company

The principal activity of the company continued to be that of the sale and marketing of group products for the surgical endoscopy market in the UK, the provision of a repair service and the development and production of surgical implements and construction of integrated operating theatres

Political and charitable donations

The company made £4,083 (2023 - £13,166) in charitable donations during the year. The company made no political contributions during the year (2023 - £Nil).

Company policy on disabled employees

During the year, the policy of providing employees with general information continued. The company places value on the involvement of its employees. Relevant information is supplied through formal and informal meetings. The company gives every consideration to applications for employment from disabled persons where the requirement of the job may be adequately covered by a handicapped or disabled person. With regard to existing employees and those who have become disabled during the period, the company has continued to examine ways and means of providing continuing employment under normal terms and conditions and to provide training and career development and promotion wherever appropriate. Equal opportunities are given to all employees for training, career development and promotion. The company involves employees in matters affecting terms and conditions of employment. Induction courses are run for new employees with a particular emphasis on Health and Safety.



Directors

The directors shown below have held office during the whole of the period from
1 January 2024 to 31 December 2024

Jayesh Purbhoo
 Ian Pritchard

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
23 August 2025

And signed on behalf of the board by:
Name: Jayesh Purbhoo
Status: Director

KARL STORZ ENDOSCOPY (UK) LIMITED

Profit And Loss Account

for the Period Ended 31 December 2024

2024 2023


£
£
Turnover: 89,925,874 83,440,983
Cost of sales: ( 62,763,400 ) ( 54,237,429 )
Gross profit(or loss): 27,162,474 29,203,554
Distribution costs: ( 13,830,479 ) ( 15,163,205 )
Administrative expenses: ( 7,887,599 ) ( 7,598,979 )
Other operating income: 6,800 6,800
Operating profit(or loss): 5,451,196 6,448,170
Interest receivable and similar income: 668,994 427,733
Interest payable and similar charges: ( 295,421 ) ( 200,278 )
Profit(or loss) before tax: 5,824,769 6,675,625
Tax: ( 1,489,610 ) ( 1,587,071 )
Profit(or loss) for the financial year: 4,335,159 5,088,554

KARL STORZ ENDOSCOPY (UK) LIMITED

Balance sheet

As at 31 December 2024

Notes 2024 2023


£
£
Called up share capital not paid: 0 0
Fixed assets
Tangible assets: 3 4,265,009 4,494,013
Total fixed assets: 4,265,009 4,494,013
Current assets
Stocks: 4 13,608,652 15,788,810
Debtors: 5 29,477,914 22,657,485
Cash at bank and in hand: 1,271,647 1,818,330
Total current assets: 44,358,213 40,264,625
Prepayments and accrued income: 113,314
Creditors: amounts falling due within one year: 6 ( 28,095,783 ) ( 24,838,091 )
Net current assets (liabilities): 16,262,430 15,539,848
Total assets less current liabilities: 20,527,439 20,033,861
Creditors: amounts falling due after more than one year: 7 ( 336,760 ) ( 306,752 )
Provision for liabilities: ( 82,988 ) 0
Accruals and deferred income: ( 780,000 ) ( 734,577 )
Total net assets (liabilities): 19,327,691 18,992,532
Capital and reserves
Called up share capital: 100,000 100,000
Profit and loss account: 19,227,691 18,892,532
Total Shareholders' funds: 19,327,691 18,992,532

The notes form part of these financial statements

KARL STORZ ENDOSCOPY (UK) LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 23 September 2025
and signed on behalf of the board by:

Name: Jayesh Purbhoo
Status: Director

The notes form part of these financial statements

KARL STORZ ENDOSCOPY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

    Turnover policy

    Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added

    Tangible fixed assets depreciation policy

    Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

KARL STORZ ENDOSCOPY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 251 231

KARL STORZ ENDOSCOPY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 January 2024 5,865,699 10,261,137 16,126,836
Additions 56,048 1,169,234 1,225,282
Disposals ( 969,389 ) ( 969,389 )
Revaluations
Transfers
At 31 December 2024 5,921,747 10,460,982 16,382,729
Depreciation
At 1 January 2024 2,836,725 8,796,098 11,632,823
Charge for year 432,030 1,020,350 1,452,380
On disposals ( 967,483 ) ( 967,483 )
Other adjustments
At 31 December 2024 3,268,755 8,848,965 12,117,720
Net book value
At 31 December 2024 2,652,992 1,612,017 4,265,009
At 31 December 2023 3,028,974 1,465,039 4,494,013

KARL STORZ ENDOSCOPY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Stocks

2024 2023
£ £
Stocks 522,752 543,287
Payments on account 13,085,900 15,245,523
Total 13,608,652 15,788,810

KARL STORZ ENDOSCOPY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Debtors

2024 2023
£ £
Trade debtors 11,392,261 11,752,987
Prepayments and accrued income 18,085,653 10,904,498
Total 29,477,914 22,657,485
Debtors due after more than one year: 0 113,314

KARL STORZ ENDOSCOPY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

6. Creditors: amounts falling due within one year note

2024 2023
£ £
Trade creditors 944,048 584,155
Taxation and social security 3,920,956 3,270,723
Accruals and deferred income 12,086,109 10,303,048
Other creditors 11,144,670 10,680,165
Total 28,095,783 24,838,091

KARL STORZ ENDOSCOPY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

7. Creditors: amounts falling due after more than one year note

2024 2023
£ £
Other creditors 336,760 306,752
Total 336,760 306,752